Results 31 to 40 of about 787 (112)
Zhongliu Fangzhi Yanjiu, 2021 Objective To investigate the imaging characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. Methods We retrospectively analyzed the clinical and imaging data of five children with Xp11.2 tRCC confirmed by surgery ...
PENG Fei, YAN Xueqiang, SHAO Jianbo
doaj +1 more source
Frontiers in Pediatrics, 2023 RCC accounts for only 0.1%–0.3% of all kidney tumors and 2%–6% of malignant kidney tumors in children. Accounting for approximately one-third of the total number of cases in children and adolescents with RCC, Xp11.2 tRCC is the most common subtype of the
Kaihang Yang +3 more
doaj +1 more source
The preliminary experiences of translocation renal cell carcinoma and literature review
Kaohsiung Journal of Medical Sciences, 2014 Xp11.2 translocation renal cell carcinoma (RCC) is rare and predominantly found in children and young adults. Because of the property of overexpressed transcription factor E3 (TFE3) fusion protein, immunohistochemical (IHC) staining with TFE3 antibody ...
Hsin-Hao Su +4 more
doaj +1 more source
Scientific Reports, 2020 NONO-TFE3 RCC is a subtype of Xp11.2 translocation renal cell carcinoma (RCC). So far, only a small amount of NONO-TFE3 RCC have been reported owing to lack of effective diagnosis methods.
Ning Liu +13 more
doaj +1 more source
Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion. [PDF]
PLoS ONE, 2014 PURPOSE: To characterize Xp11.2 translocation renal cell carcinoma (RCC) using magnetic resonance imaging (MRI) and computed tomography (CT). METHODS: This study retrospectively collected the MRI and CT data of twelve patients with Xp11.2 translocation ...
Wei Wang +6 more
doaj +1 more source
Polish Journal of Pathology, 2019 Renal cell carcinoma (RCC) is the most common renal tumour. RCC with Xp11.2 translocation/TFE3 (transcription factor E3) gene fusions (Xp11.2 RCC) is positive for immunostain labelling by TFE3 antibody. This tumour is rarely described in adults.
Jaudah Al-Maghrabi +2 more
doaj +1 more source
Journal of Hematology & Oncology, 2021 Background NONO-TFE3 translocation renal cell carcinoma (NONO-TFE3 tRCC) is one subtype of RCCs associated with Xp11.2 translocation/TFE3 gene fusions RCC (Xp11.2 tRCCs). Long non-coding RNA (lncRNA) has attracted great attention in cancer research.
Lei Yang +6 more
doaj +1 more source
Case Reports in Urology, 2013 Introduction. The recently recognized renal cell carcinomas associated with Xp11.2 translocations are rare tumors predominantly reported in children. Chromosome Xp11.2 translocation results in gene fusion related to transcription factor E3 (TFE3) that ...
Puneet Ahluwalia +2 more
doaj +1 more source
Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis. [PDF]
PLoS ONE, 2016 To investigate the clinical characteristics, treatments and prognosis of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions (Xp11.2 tRCC), the epidemiological features and treatment results of 34 cases of Xp11.2 tRCC, which were ...
Ning Liu +7 more
doaj +1 more source
Cancer Medicine, Volume 15, Issue 8, August 2026.ABSTRACT Background TFE3‐rearranged renal cell carcinoma (TFE3‐rRCC) is a rare, aggressive subtype that predominantly affects adolescents and young adults. Its marked morphologic heterogeneity can delay recognition and downstream confirmatory testing.
Yu‐Hang Chen +17 more
wiley +1 more source